Acute Myocardial Infarction Related to Methylphenidate for Adult Attention Deficit Disorder

Journal of Emergency Medicine

Volumn 38, Issue 1, 2010, Pages 18-21

  Thompson, Jan ^a   Thompson, James R ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Adult Attention Deficit Disorder; methylphenidate; myocardial infarction; psychostimulants

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; CLOPIDOGREL; HEPARIN; KETOROLAC; LIDOCAINE; METHYLPHENIDATE; PSEUDOEPHEDRINE;

ACUTE HEART INFARCTION; ADULT; ANAMNESIS; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CORONARY ARTERY SPASM; ELECTROCARDIOGRAM; FAMILY HISTORY; HEART CATHETERIZATION; HOSPITAL DISCHARGE; HUMAN; MALE; PRIORITY JOURNAL; URINALYSIS; VITAL SIGN;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CORONARY VASOSPASM; HUMANS; MALE; METHYLPHENIDATE; MYOCARDIAL INFARCTION;

EID: 74049156203     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2007.06.021     Document Type: Article

References (17)

1. The Associated Press. Adult use of ADHD medicine surges (Thursday, September 15, 2005). http://www.cnn.com/2005/HEALTH/09/15/adults.adhd.drugs.ap/index.html Accessed September 16, 2005
2. Gutgesell H., Atkins D., Barst R., et al. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: a statement for healthcare professional from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 99 (1999) 979-982
3. Findling R.L., Short E.J., and Manos M.J. Short-term cardiovascular effects of methylphenidate and adderall. J Am Acad Child Adolesc Psychiatry 40 (2001) 525-529
4. Rappley M.D. Safety issues in the use of methylphenidate. An American perspective. Drug Saf 17 (1997) 143-148
5. Weiss M., and Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ 168 (2003) 715-722
6. Markowitz J.S., and Patrick K.S. Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit disorder. Clin Pharmacokinet 40 (2001) 753-772
7. Kimko H.C., Cross J.T., and Abernethy D.R. Pharmacokinetics and clinical effectiveness of methylphenidate. Clin Phamacokinet 37 (1999) 457-470
8. New York Times. Warning urged on stimulants like ritalin (February 10, 2006). http://www.nytimes.com/2006/02/10/health/policy/10drug.html?ex=1169269200&en=0d2e2a0d2b871f18&ei=5070 Accessed February 13, 2006
9. U.S. News & World Report. The FDA requires a warning on ADHD drugs. http://www.usnews.com/usnews/health/articles/070221/21.ritalin.htm Accessed March 19, 2007
10. th edn. (2002), McGraw-Hill, New York, NY 1020-1033
11. George A.K., Kunwar A.R., and Awasthi A. Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin. J Child Adolesc Psychopharmacol 15 (2005) 693-695
12. Wright S., and Tomassoni A. Acute myocardial infarction following therapeutic use of pseudoephedrine (abstract). Vet Hum Toxicol 36 (1994) 366
13. Wiener I., Tilkian A.G., and Palazzolo M. Coronary artery spasm and myocardial infarction in a patient with normal coronary arteries: temporal relationship to pseudoephedrine ingestion. Cathet Cardiovasc Diagn 20 (1990) 51-53
14. Rosen R.A. Angina associated with pseudoephedrine. Ann Emerg Med 10 (1981) 230-231
15. Porta M., Jick H., and Habakangas J.A.S. Follow-up study of pseudoephedrine users. Ann Allergy 57 (1986) 340-342
16. th edn. (2002), Mosby, St. Louis, MO 2119-2125
17. Hollander J.E. The management of cocaine-associated myocardial ischemia. N Engl J Med 333 (1995) 1267-1271